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Abstract 
Background: The development of oral squamous cell carcinoma (OSCC) is a multistep 
process that involves in both genetic alterations and epigenetic modifications. Previous studies 
suggest SOX4 might function as an oncogene or a tumor suppressor in different types of cancers. 
However, whether SOX4 involves in promoting the progression of oral precancer to cancer is 
unknown. 
Methods: Liquid chromatography with tandem mass spectrometry (LC-MS/MS) was used to 
identify the proteins that may be differentially expressed between oral lichen planus (OLP) and 
OLP-associated OSCC (OLP-OSCC) formalin-fixed paraffin-embedded (FFPE) tissues. 
Immunohistochemistry (IHC) and Western blotting were performed to evaluate SOX4 
expression between OLP and OLP-OSCC tissues and among oral cancer cell lines and normal 
human oral keratinocytes (NHOKs). SOX4 siRNA was used to knock down the expression of 
SOX4 in UM1 oral cancer cells. MTT, cell counting, migration and Matrigel invasion assays were 
utilized to examine the effect of SOX4 down-regulation on proliferation, migration and invasion 
capacity of UM1 cells.  
Results: LC-MS/MS analysis showed that 88 proteins including SOX4 were only identified in 
OLP-OSCC FFPE tissues when compared to OLP FFPE tissues. IHC confirmed that SOX4 
expression was significantly higher in OLP-OSCC than OLP and Western blot analysis indicated 
that SOX4 was over-expressed in UM1/UM2 cells when compared to NHOKs. Knockdown of 
SOX4 significantly inhibited the proliferation, migration and invasion of UM1 cells (P<0.01). 
Conclusions: Our study indicated that SOX4 is significantly upregulated in OLP-OSCC versus 
OLP tissues. In addition, down-regulation of SOX4 led to significantly reduced proliferation, 
migration and invasion capability of oral cancer cells. These findings suggest that SOX4 might be 
actively involved in the progression of OLP to OSCC. 
Key words: Invasion; Migration; Oral lichen planus; Oral squamous cell carcinoma; SOX4 
Introduction 
Despite the advances in surgery, radiation 
therapy and chemotherapy, oral squamous cell 
carcinoma (OSCC) remains to be a challenging public 
health problem worldwide [1-2]. The 5-year overall 
survival rate following treatment for OSCC has been 
stagnant at 50% in the past few decades [3-4]. The 
main reasons for the poor prognosis is that early 
molecular events responsible for the progression of 
oral precancer to cancer are poorly understood, and 
most OSCC cases are diagnosed at the advanced 
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stage. This highlights the importance of studying the 
underlying molecular mechanisms and developing 
molecular biomarkers for early detection of this 
devastating disease.  
In human, SOX (sex-determining region 
Y-related high-mobility-group box transcription 
factor) gene family has at least 20 members [5]. SOX4, 
one of group-C SOX genes, plays an important role in 
the regulation of transcription during developmental 
processes such as embryonic cardiac development, 
nervous system development, osteoblastic 
differentiation, and thymocyte development [6]. 
Recently, multiple studies reported altered expression 
of SOX4 in human cancers. SOX4 was found to be 
overexpressed in prostate cancer (PCa) and its 
expression level was closely correlated with prognosis 
[7]. In fact, upregulation of SOX4 in PCa was induced 
by PTEN loss as a result of the activation of 
PI3K-AKT-mTOR signaling [8]. SOX4 was identified 
as a master regulator of epithelial-mesenchymal 
transition (EMT) by directly regulating the expression 
of the epigenetic modifier Ezh2 in breast cancer, 
indicating SOX4 might be indispensable for tumor 
progression [9]. However, studies also showed that 
SOX4 was significantly down-regulated in 
metastatic melanoma compared with dysplastic nevi 
and primary melanoma. In addition, knockdown of 
SOX4 promoted the migration and invasion of 
melanoma cells in an NF-κB p50-dependent manner, 
suggesting that SOX4 might function as a tumor 
suppressor gene in melanoma [10].  
Oral lichen planus (OLP) is a chronic 
inflammatory disease which presents as white 
striations, white papules, white plaques, erythema, 
erosions or blisters affecting predominantly buccal 
mucosa, tongue and gingivae, although other oral 
sites may be occasionally involved [11]. The World 
Health Organization (WHO) classifies OLP as a 
“premalignant disorder” with unspecified malignant 
transformation risk and suggests that OLP patients 
should be under close monitoring. Clinically, OLP is 
characterized by T-cell-mediated chronic immune 
response and abnormal epithelial keratinization cycle. 
However, the etiology of OLP is poorly understood 
and the molecular mechanisms underlying OLP 
progression to OSCC remains largely unknown. 
Further investigation of the genetic/protein 
alterations in OLP and associated OSCC is warranted, 
which will lead to an improved understanding of the 
malignant potential of OLP and help diagnose and 
treat OLP-associated OSCC patients at early stage.  
Although SOX4 seems to be a crucial regulator 
responsible for cancer initiation and progression, 
whether it involves in the progression of oral 
precancer to OSCC is unknown. Thus, in this study, 
we aim to investigate if SOX4 is differentially 
expressed between OLP and OLP-OSCC and whether 
SOX4 has a functional role in the proliferation, 
migration and invasion of oral cancer cells. 
Materials and methods 
Tissue samples and immunochemistry (IHC) 
The study was approved by the UCLA 
Institutional IRB Committee. Archived FFPE tissues of 
OLPs and OLP-OSCCs were used for liquid 
chromatography with tandem mass spectrometry 
(LC-MS/MS) and IHC. To perform IHC analysis, 
FFPE tissue sections were deparaffinized by 
sequential washing with xylene, 100% ethanol, 95% 
ethanol, 80% ethanol and PBS. The sections were 
incubated with 0.3% H2O2 in methanol for 5 min to 
quench the endogenous peroxidase activity. The 
slides were blocked in PBS with 5% BSA for 30 min 
and then incubated overnight with a 1:100 dilution of 
anti-SOX4 primary antibody (Abcam, Cambridge, 
MA, USA) at 4 °C. After sections were rinsed with 
PBS, they were incubated with horseradish 
peroxidase (HRP)-conjugated anti-rabbit IgG (1:2000; 
GE Healthcare, Piscataway, NJ, USA) for 2 h at room 
temperature. 
Protein extraction for mass spectrometry 
Intact proteins were isolated from the FFPE 
tissues of OLP (n=6) and OLP-OSCC (n=6) with the 
Qproteome FFPE Tissue kit (Qiagen, Valencia, 
CA, USA). In total, 5 μg of proteins from pooled OLP 
or OLP-OSCC sample were digested with 50 ng 
enzyme-grade trypsin (Promega, Madison, WI, USA) 
for overnight. LC-MS/MS of the resulting peptides 
was performed using a NanoLC system (Eksigent 
Technologies, Dublin, CA, USA) and a LTQ mass 
spectrometer (Thermo Fisher, Waltham, MA, USA). 
The peptides were concentrated and desalted on a 
C18 IntegraFrit Nano-Precolumn (New Objective, 
Woburn, MA, USA) for 10 min, then eluted and 
resolved using a C18 reversed-phase capillary column 
(New Objective). LC separation was performed at 400 
nL/min with the following mobile phases: A, 5% 
acetonitrile/0.1%formic acid (v/v); B, 95% 
acetonitrile/0.1% formic acid (v/v). The chosen LC 
gradient was: from 5% to 15% B in 1 min, from 15% to 
100% B in 40 min, and then maintained at 100%B for 
15 min. Database searches were performed using the 
X! Tandem search engine against the SwissProt 
protein sequence database. The search criteria were 
set with a mass accuracy of 0.4 Da and semi-style 
cleavage by trypsin. Proteins with two unique 
peptides are considered as positively identified. 
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Cell culture 
Normal human oral keratinocytes (NHOKs) 
were maintained in the EpiLife media supplemented 
with the human keratinocyte growth supplement 
(Invitrogen). UM1 and UM2 oral cancer cell lines were 
cultured in the Dulbecco’s modified eagle medium 
(DMEM) plus 10% fetal bovine serum, penicillin 
(100 U/mL), and streptomycin (100 μg/mL). The cells 
were maintained at 37°C in a humidified 5% 
CO2 incubator and passaged when they reached 
90-95% confluence. 
siRNA knockdown of SOX4 
UM1 cells were transfected with siRNA in 
96-well or 6-well plates using the Lipofectamine 3000 
transfection regent (Invitrogen, Carlsbad, CA, USA) 
according to the company’s instruction. Validated 
double-stranded siRNAs of SOX4 (sc-38412) or 
non-target control siRNAs (Santa Cruz Biotech, Santa 
Cruz, CA, USA) were mixed with the transfection 
reagent and then added to the cell culture. After 
overnight incubation, the siRNAs were removed and 
the cells were further cultured in fresh media for 48 h. 
Western blotting 
Protein samples were separated with a 4-12% 
Bis-Tris NuPAGE gel (Invitrogen) and transferred 
onto nitrocellulose membrane by the Trans-blot SD 
semi-dry transfer cell (Bio-Rad, Brea, CA, USA). The 
membranes were blocked in TBST buffer containing 
5% nonfat milk (Santa Cruz Biotech), and incubated 
with rabbit antibody against human SOX4 at a 
dilution of 1:500 (Abcam) overnight, followed by HRP 
linked goat anti-rabbit IgG (1:5000; GE Healthcare). 
The detection was performed with the ECL-Plus 
Western blotting reagent kit (GE Healthcare). 
MTT assay 
UM1 cells are highly invasive while UM2 cells 
have low invasive capacity. Therefore, we choose 
UM1 cell line as the in vitro model for functional 
analysis. After 24 h of serum starvation, the siRNA 
transfected cells were seeded into a 96-well plate at a 
density of 4000 cells/well in 100 μL medium for the 
MTT assay. At the indicated time points, 20μL of MTT 
(Sigma-Aldrich, St. Louis, MO, USA) dissolved in PBS 
at 5 mg/ml was added to each culture well. 
Following by incubation for 4 h at 37 °C, the 
supernatant was then discarded and the precipitate 
dissolved in 200 μl of dimethyl sulfoxide (DMSO, 
Sigma). The absorbance of each well was measured 
using a Synergy HT microplate reader (BioTek 
Instruments, Winooski, VT, USA) at 490 nm. 
Cell counting assay  
Cells were harvest from 10-cm petri dish with 
0.25% trypsin treatment to prepare single-cell 
suspension, followed by counting the cells with a 
vi-cell® cell counter (Beckman Coulter, Inc. Brea, 
CA, USA). Then the cells were seeded into 12-well 
plates at a density of 1 x105 cells per well. At the 
indicated time points, cells were harvested and 
resuspended in 500 µL complete media and subjected 
to cell counting analysis.  
Wound healing assay 
Wound healing assay was used to evaluate the 
migratory ability of siRNA-transfected UM1 cells. 
Briefly, 5x105 cells were seeded into a 6-well plate and 
were allowed to grow to confluent cell monolayers. 
Subsequently, four vertical wounds were generated 
per well using a micropipette tip. The plate was then 
returned to the tissue culture incubator. For 
quantification, images at the beginning and after 8 h 
were captured and the distance between the edges of 
the wound were calculated and analyzed by the NIH 
Image J software. 
Invasion assay 
The invasion assays were performed with the 
Matrigel-coated transwells. Following 24 h serum 
starvation, cells were harvested and resuspended in 
the DMEM media containing 0.1% FBS, and 5 x104 
cells were then added to the upper chamber of 
transwell inserts. DMEM containing 10% FBS was 
used as chemoattractant in the lower chamber. After 
24 h, cells that had migrated through the membrane 
were fixed and stained with the HEMA 3 staining kit 
(Thermo Fisher Scientific, Pittsburgh, PA, USA). The 
invaded cells in four random fields were counted and 
expressed as the average number of cells per field 
under light microscopy (Eclipse TE2000, Nikon, 
Tokyo, Japan). 
Statistical analysis 
The data were expressed as the mean ± standard 
deviation, and analyzed by the independent samples 
t-test using the MedCalc (MedCalc Software, Ostend, 
Belgium). P values < 0.05 were considered as 
statistically significant. 
Results 
SOX4 was over-expressed in OLP-OSCC 
versus OLP 
We isolated intact proteins from archived FFPE 
tissues of OLPs and OLP-OSCCs using the 
Qproteome FFPE Tissue kit and then analyzed the 
protein samples with LC-MS/MS and database 
searching. In total, 96 and 142 proteins were identified 
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in the pooled OLP FFPE tissue sample (n=6) and the 
pooled OLP- OSCC FFPE tissue sample (n=6), 
respectively (Fig.1 and supplementary data). 
Fifty-four proteins were commonly detected between 
OLP and OLP-OSCC FFPE tissues, and 88 proteins 
including SOX4 were only identified in OLP-OSCC. A 
list of tumor promoting proteins that only detected in 
OLP-OSCC was summarized in Table 1. 
The expression level of SOX-4 in clinical samples 
was further assessed using IHC. The positive staining 
of cells was identified as yellow-brown granules. The 
intensity of SOX4 staining was significantly stronger 
in OLP-OSCC than OLP tissues (Fig. 2). 
 
 
 
Fig. 1. The commonly and differentially expressed proteins between the 
archived FFPE tissues of OLP and OLP-OSCC. OLP-OSCC were progressed 
from OLP of the same patients. Proteins were isolated from archived FFPE 
tissues with the Qproteome FFPE tissue kit and identified by LC-MS/MS and 
database searching. Forty-two proteins were only identified from the FFPE 
tissues of OLP while 88 proteins were only identified from FFPE tissues of 
OLP-OSCC.  
 
Table 1. A list of proteins that only detected in OLP-OSCC 
Accession 
No 
# of 
Peptide 
Protein name Molecular function 
Q06945 2 SOX-4 DNA binding 
Q9NZT1 2 Calmodulin-like protein 5 Calcium binding 
P17813 2 Endoglin Angiogenesis regulation 
P15502 2 Elastin ECM structural 
constituent 
P05164 4 Myeloperoxidase Peroxidase activity 
P60174 3 Triosephosphate 
isomerase 
Ubiquitin protein ligase 
binding 
P32119  2 Peroxiredoxin-2 Redox regulation 
Q15084 2 Protein 
disulfide-isomerase A6 
Cell redox homeostasis 
P19971 2 Thymidine phosphorylase Angiogenesis regulation 
P30044 2 Peroxiredoxin-5, 
mitochondrial 
Redox regulation 
 
SOX4 was over-expressed in OSCC cell lines 
Western blot analysis showed that SOX4 was 
significantly over-expressed in both UM1 and UM2 
cells compared to NHOKs, which is in line with IHC 
results and further confirms that SOX4 is 
overexpressed in oral cancer cells (Fig. 3A). 
Knockdown of SOX4 in UM1 oral cancer cells 
UM1 cells were successfully transfected with 
siSOX4 by using the Lipofectamine 3000 reagent. 
Western blotting results showed that the protein 
expression level of SOX4 was significantly lower in 
the UM1 cells transfected with siSOX4 when 
compared to the UM1 cells transfected with control 
siRNA (Fig. 3B). 
 
 
Fig.2. The expression level of SOX4 in OLP and OLP-OSCC FFPE tissues. The IHC results showed that the distribution and intensity of SOX4 staining in OLP-OSCC 
was significantly broader and stronger than that in OLP tissues (From left to right, scale bar, 25 µm, 50 µm or 100µm) 
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Fig.3. (A) Significant over-expression of SOX4 in UM1 and UM2 oral cancer cells versus NHOKs (normal cells). (B) Knockdown of SOX4 in UM1 cells with siRNA. 
 
Knockdown of SOX4 inhibited the 
proliferation of UM1 cells 
To assess the role of SOX4 in the proliferation of 
OSCC, MTT assay and cell counting assay were 
performed using oral cancer cells transfected with 
siRNA against SOX4 or control siRNA at different 
time points (24, 48, and 72h). The results showed that 
the number of oral cancer cells in the SOX4 
suppression group was significantly lower in 
comparison with the negative control group at 48h 
and 72h (**P <0.01) (Fig.4). 
Knockdown of SOX4 suppressed the migration 
capacity of UM1 cells 
For wound healing assay, the effect of SOX4 
inhibition on cell migration was determined at 8 h 
after the cells reached confluence. As shown in Figure 
5, relative to control cells, cells treated with siSOX4 
reduced the migration capacity significantly. The 
empty space between cell layers was significantly 
greater in siSOX4 treated cells as compared to the 
control cells (P<0.01) (Fig.5).  
Knockdown of SOX4 suppressed the invasion 
capability of UM1 cells 
To investigate whether SOX4 involves in 
regulation invasion capability of oral cancer cells, 
Matrigel invasion assay was used to evaluate the 
motility of UM1 cells after SOX4 suppression. 
Compared with control cells, SOX4 knockdown UM1 
cells showed about 68 % reduction in the number of 
cells crossing the membrane (P<0.01) (Fig. 6).  
 
 
Fig.4. Effect of SOX4 inhibition on the proliferation of UM1 oral cancer cells. 
Both cell counting (A) and MTT (B) assay results showed that SOX4 
downregulation inhibited the proliferation of UM1 cells at 48h and 72h (**, P < 
0.01). 
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Fig.5. Effect of SOX4 inhibition on the migration of UM1 oral cancer cells. The percentage of wound closed in the siSOX4 transfected UM1 cells was significantly less 
than the cells transfected with siCTRL (**, P < 0.01) (Scale bar, 100µm). 
 
Fig.6. Effect of SOX4 inhibition on the invasion of UM1 oral cancer cells. siSOX4 transfected UM1 cells showed about 68 % reduction in the number of cells invading 
through the membrane in comparison with those cells transfected with siCTRL (**, P < 0.01) (Scale bar, 100µm). 
 
Discussion 
In this study, we have clearly demonstrated that 
SOX4 is over-expressed in OLP-OSCC versus OLP. It 
should be noted that the OSCC in the study 
progressed from the OLP of the same patients. We 
have also shown that down-regulation of SOX4 in 
UM1 oral cancer cells significantly impairs the cell 
proliferation, migration and invasion, suggesting that 
SOX4 may have a potential role in promoting the 
progression of OLP-associated oral cancer.  
Oral carcinogenesis is a multistep 
process characterized by genetic alterations that 
influence key cellular pathways of growth and 
development. To date, the underlying molecular 
mechanisms responsible for OSCC initiation and 
development, especially the progression of oral 
precancer to cancer, are inadequately understood. 
Multiple types of oral precancerous lesions including, 
but not limited to, oral leukoplakia, OLP, oral 
submucous fibrosis, oral erythroplakia and actinic 
cheilitis, may progress to OSCC at different 
conversion rate. In fact, OLP is defined by the WHO 
as a precancerous lesion which should be closely 
monitored for the risk of cancer development. It is a 
good clinical model for understanding the role of 
chronic inflammation in oral carcinogenesis. To the 
best of our knowledge, this is the first LC-MS/MS 
study revealing the differentially expressed proteins 
in the archived FFPE tissues between OLP and 
OLP-associated OSCC. It appeared to be challenging 
for us to use LC-MS/MS for the analysis of isolated 
proteins from archived FFPE tissues. We initially 
tested LC-MS/MS with iTRAQ (isobaric tagging for 
relative and absolute quantification) for quantification 
of intact proteins isolated from FFPE tissues. 
However, the iTRAQ labeling of peptides failed in our 
experiments presumably due to cross-linking of 
proteins in archived FFPE tissues. Therefore, we had 
to use a direct LC-MS/MS identification method to 
compare the proteins identified from FFPE tissues 
between OLP and OLP-OSCC. Even with the direct 
LC-MS/MS identification method, we were unable to 
identify a large number of proteins from archived 
FFPE tissues, which again might be due to that 
cross-linking altered the molecular weights of 
proteins and peptides. Nevertheless, a number of 
proteins that promote cancer progression were only 
detected in OLP-OSCC, and further investigation of 
these proteins may reveal their potential clinical 
significance in early stage of OSCC.  
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Our findings based on LC-MS/MS, IHC and 
functional analyses are in line with those from 
previous studies. Yoon et al. reported that SOX4 was 
significantly upregulated in OSCC tissues compared 
to adjacent normal mucosa and contributed to 
oncogenic phenotypes of oral cancer cells by 
promoting cell survival and elevating 
chemoradioresistance [12]. Watanabe et al. found that 
SOX4 expression levels were significantly correlated 
with various clinicopathological parameters of OSCC 
including gender, T status, and stage levels, and 
increased SOX4 expression was detected in poorly 
differentiated OSCC or in the metastatic focus [13]. In 
addition to OSCC, studies have demonstrated that 
SOX4 may play an oncogenic role in other solid 
malignant tumors [14-17]. Zhang et al. elucidated that 
SOX4 was a direct target of C/EBPα and 
downregulation of SOX4 suppressed the self-renewal 
of leukemic cells and restored their differentiation, 
indicating that SOX4 overexpression resulting from 
inactivation of C/EBPα promotes leukemia 
development [18]. Zhang et al. discovered that 
SOX4 positively regulated the epithelial- 
mesenchymal transition (EMT) process and may 
combine with oncogenic Ras together to promote 
tumorigenesis in vivo [19]. However, it should be 
noted that some of the published studies reported a 
tumor suppressor function of SOX4. For instance, Li et 
al. found that SOX4 was essential for p53 activation in 
response to DNA damage. In addition, SOX4 could 
interact with and stabilize p53 protein by inhibiting 
Mdm2-mediated p53 ubiquitination and degradation, 
suggesting that SOX4 might suppress the progression 
DNA damage response-associated cancer [20]. Wang 
et al. reported that over-expression of SOX4 in 
primary gallbladder carcinoma (PGC) was 
significantly associated with favorable clinical 
parameters such as low histologic grade, low 
pathologic T stage, and early clinical stage. In 
addition, SOX4 upregulation was an independent 
prognostic factor for better overall and disease-free 
survival in patients with PGC [21]. Taken together, 
these previous findings seem to suggest that the 
concrete role of SOX4 is closely associated with tumor 
microenvironment and might be tissue specific. 
Conclusion 
Our study demonstrated that SOX4 was 
overexpressed when OLP progressed to OSCC. In 
addition, SOX4 might have a functional role in OSCC 
by modulating the proliferation, migration and 
invasion of oral cancer cells. Further studies are 
needed to validate the clinical significance of SOX4 in 
the early stage OSCC so that this target protein may 
be applied to early detection of the malignancy.  
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